(Q48627146)

13 February 2018

title

Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome. (English)

1 reference

13 February 2018

1 reference

1

1 reference

13 February 2018

Xiongwei Zhu

10

object named as

Xiongwei Zhu

1 reference

13 February 2018

9

Mark A Smith

1 reference

13 February 2018

8

Gemma Casadesus

1 reference

13 February 2018

author name string

Mike Snape

2

1 reference

13 February 2018

Eric Klann

3

1 reference

13 February 2018

Jeremy G Stone

4

1 reference

13 February 2018

Avneet Singh

5

1 reference

13 February 2018

Robert B Petersen

6

1 reference

13 February 2018

Rudy J Castellani

7

1 reference

13 February 2018

language of work or name

English

0 references

publication date

27 March 2012

1 reference

13 February 2018

Journal of Neurochemistry

published in

1 reference

13 February 2018

volume

121

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

page(s)

672-679

1 reference

13 February 2018

Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

The mGluR theory of fragile X mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Enhanced Ras activity promotes spine formation in synRas mice neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Origins of epilepsy in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Autism profiles of males with fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Potential therapeutic interventions for fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

ERK activation causes epilepsy by stimulating NMDA receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Resistance to MEK inhibitors: should we co-target upstream?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

MAP'ing CNS development and cognition: an ERKsome process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

ERK2 contributes to the control of social behaviors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

A necessity for MAP kinase activation in mammalian spatial learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

MAPK cascade signalling and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Spry2 expression correlates with BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

The role of mitogen-activated protein kinase pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

Distribution, levels, and activation of MEK1 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07722.X

10.1111/J.1471-4159.2012.07722.X

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018